Waters' Q2 Revenues Increase 14 Percent but Miss Analyst Estimates | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today reported revenues grew 14 percent year over year in the second quarter, but missed analysts' estimates on soft sales to government and academic customers.

For the three months ended July 2, the company posted $447.6 million in revenues, up from $391.1 million a year ago, but short of Wall Street's consensus estimate of $451.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.